Tinnitus Explained: Symptom vs Diagnosis

NINDS Trial Explained Stroke Thrombolysis Risks and Benefits

Stroke thrombolysis changed emergency neurology forever—but understanding why the NINDS trial mattered is what transforms memorization into clinical decision-making. In this episode of This Is Why with Dr. Busti, we break down the landmark NINDS rt-PA trial that established alteplase as a treatment for acute ischemic stroke and explore the real-world balance between functional recovery and intracerebral hemorrhage risk. Dr. Busti explains how to interpret the trial beyond headlines by walking through the study design, inclusion criteria, outcomes, NNT and NNH calculations, odds ratios, bleeding risk, and the evolution of thrombolytic therapy from alteplase to tenecteplase. This episode also contextualizes modern AHA/ASA recommendations and what clinicians should actually say during bedside risk-benefit discussions with patients and families. This Is Why medical education focuses on understanding the “why” behind clinical decisions so healthcare professionals can apply evidence with confidence and clarity. Topics Covered: - NINDS rt-PA trial explained - Alteplase for acute ischemic stroke - Stroke thrombolysis risks and benefits - Functional recovery vs hemorrhage risk - NNT and NNH interpretation - Odds ratio vs absolute risk - Tenecteplase vs alteplase - Modern stroke thrombolysis guidelines - Shared decision-making in stroke care - Why early reperfusion matters The goal = make medical education easy and clinically relevant. 👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/ninds-trial-stroke-thrombolysis-risks-benefits 🎥 Watch other videos referenced in this episode! P-Value: https://youtu.be/ibl85Flpm94 Alpha Value Explained: https://youtu.be/Fmu4HwaGrtU Power Analysis - Type II Error Risk: https://youtu.be/zn9q9E1IOoc 👉 Get more with a free membership at https://www.thisiswhy.health/ - Access free downloads from our videos  - Access deep dive content from Dr. Busti - Organize content via playlists & collections - Join live Q&A - Receive member newsletters - Coupons & discounts for exam prep resources Chapter Table of Contents 00:00 - Introduction 01:46 - NINDS Trial (1995) 04:40 - Trial Design, Inclusion & Exclusion Criteria 06:38 - Part 1: The Negative 24-Hour Endpoint Explained 11:28 - Part 2: Functional Outcomes That Changed Practice 13:45 - NNT, NNH & Explaining Risk to Patients 19:18 - One-Year Outcomes & Interpreting Odds Ratios Correctly 22:09 - Later Evidence, Meta-Analyses & Expanded Treatment Windows 25:30 - Tenecteplase vs Alteplase & Modern Stroke Practice 28:17 - Conclusion 👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content. 🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more! #AcuteIschemicStroke #NINDSTrial #StrokeThrombolysis #Alteplase #Tenecteplase #DrBusti Speaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

95% Confidence Intervals Explained for Medical Literature

Confidence intervals are one of the most misunderstood concepts in evidence-based medicine. In this episode of This Is Why with Dr. Busti, we break down what 95% confidence intervals actually mean, how they relate to p values and effect size, and why they are essential for interpreting clinical research correctly. Dr. Busti walks through practical examples involving odds ratios, hazard ratios, relative risk, forest plots, and statistical significance so healthcare professionals can confidently evaluate published literature and apply evidence appropriately in clinical decision-making. Whether you're preparing for boards, learning research interpretation, or improving your evidence-based medicine skills, this episode helps transform statistical confusion into clinical understanding. Topics Covered: - What a 95% confidence interval actually means - Why confidence intervals matter in inferential statistics - Relationship between confidence intervals and p values - Understanding statistical significance - Why confidence intervals can be wide or narrow - Sample size and precision of results - Interpreting odds ratios and hazard ratios - Why crossing 1.0 matters for ratios - Why crossing 0 matters for means - Forest plot interpretation basics - Clinical relevance versus statistical significance - Confidence intervals in meta-analyses - Understanding random error and confounding - Examples from cardiovascular literature - Evidence-based medicine interpretation strategies This Is Why with Dr. Busti helps healthcare professionals move beyond memorization by understanding the why behind clinical evidence and patient care decisions. 👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/confidence-intervals-explained-medical-statistics 👉 Get more with a free membership at https://www.thisiswhy.health/ - Access free downloads from our videos  - Access deep dive content from Dr. Busti - Organize content via playlists & collections - Join live Q&A - Receive member newsletters - Coupons & discounts for exam prep resources Chapter Table of Contents 00:00 - Introduction 01:52 - Concept Overview 03:29 - What a 95% Confidence Interval Really Means 04:39 - Why Narrow CI Matter 07:10 - Statistical Significance of CI 08:57 - Sample Question 12:01 - Integration & Application 12:56 - PROactive Trial & Aspirin Meta-Analysis 22:07 - Impact of Controlling for Confounders 24:01 - Conclusion 👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content. 🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more! #evidencebasedmedicine #confidenceinterval #statistics #clinicalresearch #medicaleducation #DrBusti Speaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Tinnitus Explained: Symptom vs Diagnosis

Tinnitus explained clearly—This Is Why it matters clinically with Dr. Busti. Understanding tinnitus as a symptom, not a diagnosis, changes how you think, communicate, and manage patients. In this episode, Dr. Busti breaks down the meaning of tinnitus, its clinical implications, and how proper terminology drives better clinical reasoning. From pathophysiology to medication causes and key descriptors like pulsatile and unilateral tinnitus, this is a foundational concept every healthcare professional must master. This Is Why terminology is more than vocabulary—it’s a tool for thinking. Topics Covered: - What tinnitus actually means clinically - Why tinnitus is a symptom, not a diagnosis - Common patient descriptions of tinnitus - Pathophysiology and brain compensation - Pulsatile vs non-pulsatile tinnitus - Unilateral vs bilateral tinnitus significance - Medication-induced tinnitus causes - Aminoglycosides, loop diuretics, salicylates - Correct pronunciation and why it matters - Clinical reasoning approach to tinnitus - Real-world coping strategies (sound masking) - Cultural references and patient perspective The goal = make medical education easy and clinically relevant. 👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tinnitus-explained-symptom-vs-diagnosis-medical-terminology 👉 Get more with a free membership at https://www.thisiswhy.health/ - Access free downloads from our videos  - Access deep dive content from Dr. Busti - Organize content via playlists & collections - Join live Q&A - Receive member newsletters - Coupons & discounts for exam prep resources 👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content. #tinnitus #tinnitusmeaning #clinicalreasoning #hearingloss #Dr Busti Speaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

P Values Explained Clearly: Statistical vs Clinical Significance

P values explained clearly in clinical research — This Is Why understanding what a P value means (and does NOT mean) with Dr. Busti is critical for interpreting evidence and applying it to patient care. In this episode, Dr. Busti breaks down one of the most misunderstood concepts in biostatistics: the P value. You’ll learn exactly what a P value tells you about chance, random error, and statistical significance—and more importantly, what it does NOT tell you about clinical relevance. Using landmark clinical trials, including real-world examples, this episode connects statistical interpretation to actual patient care decisions so you can move beyond memorization and truly understand the “why” behind the data. Topics Covered: - What a P value actually represents - What a P value does NOT mean - Why P values do not determine clinical significance - Interpreting P values as probabilities of chance - Relationship between P values and null hypothesis - Type I error and limitations of P values - Role of bias, power, and random error - UKPDS trial interpretation and sample size impact - HOPE trial interpretation and clinical relevance - Statistical vs clinical significance in practice - Internal vs external validity 👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/p-value-interpretation-clinical-significance-board-question 👉 Get more with a free membership at https://www.thisiswhy.health/ - Access free downloads from our videos  - Access deep dive content from Dr. Busti - Organize content via playlists & collections - Join live Q&A - Receive member newsletters - Coupons & discounts for exam prep resources 👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content. 🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more! #pvalue #statisticalsignificance #clinicalresearch #evidencebasedmedicine #DrBusti Speaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Why Sulfonylureas Cause Hypoglycemia Explained

Why sulfonylureas cause hypoglycemia becomes much easier to understand once you know how pancreatic beta cells regulate insulin secretion. In this episode of This Is Why with Dr. Busti, we walk through a board-style pharmacology question that connects ATP-sensitive potassium channels, membrane depolarization, calcium influx, and insulin release into one clinically useful framework. Instead of memorizing isolated diabetes medication facts, this episode explains the physiology behind insulin secretagogues and why missed meals can become dangerous in patients taking sulfonylureas or meglitinides. Dr. Busti breaks down the mechanism step-by-step so you can reason through pharmacology questions, recognize common board-style distractors, and apply the concepts clinically. This Is Why stronger pharmacology understanding improves both exam performance and patient care. Topics Covered: - Hypoglycemia caused by sulfonylureas - Meglitinide mechanism of action - ATP-sensitive potassium channels - Pancreatic beta-cell physiology - Insulin secretion pathway - Membrane depolarization in beta cells - Calcium influx and insulin release - Board-style pharmacology reasoning - High-yield endocrinology pharmacology - Missed meal hypoglycemia risk - Toxicology and recurrent hypoglycemia - Octreotide in sulfonylurea toxicity - Clinical reasoning for diabetes medications - Mechanism-based test-taking strategies 👉 Get more with a free membership at https://www.thisiswhy.health/ - Access free downloads from our videos  - Access deep dive content from Dr. Busti - Organize content via playlists & collections - Join live Q&A - Receive member newsletters - Coupons & discounts for exam prep resources 👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content. #Sulfonylureas #Hypoglycemia #InsulinSecretion #BetaCellPhysiology #DrBust Speaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.